Hyderabad is rapidly establishing as a major life sciences hub, attracting global capability centres (GCCs) and recording impressive growth in the sector.
Amgen, a US-based biopharmaceutical company, has inaugurated its largest innovation centre in Hyderabad, with plans for further investment in the city.
Hyderabad's dominance in the life sciences industry was highlighted at the BioAsia 2025 summit, with major players expanding their presence in the city.
Hyderabad is witnessing a surge in R&D and biotech investments, strengthening its biotech ecosystem and receiving significant investments in the biopharma sector.
The city's global collaborations, policy initiatives, and plans for a dedicated Life Sciences University further contribute to its growth and development.